Preclinical Evaluation of an Everolimus-Eluting Bioresorbable Vascular Scaffold Via a Long-Term Rabbit Iliac Artery Model. [PDF]
Park DS +16 more
europepmc +1 more source
Neoatherosclerosis as the Cause of Late Failure of a Bioresorbable Vascular Scaffold
A 48-year-old man who underwent uneventful 3.0 × 28 mm bioresorbable vascular scaffold (BVS) implantation on the mid left anterior descending coronary artery for stable angina, presented 15 months later with unstable angina.
Mangiameli A +4 more
openaire +2 more sources
Freedom From Stent Fracture-Related Complications of Vascular Longitudinal Remodeling in a Patient With Heart Failure and a Degraded Bioresorbable Vascular Scaffold. [PDF]
Chang CJ +4 more
europepmc +1 more source
Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice. [PDF]
Lee JM +30 more
europepmc +1 more source
Bioresorbable vascular scaffolds: the promise of transience [PDF]
J B, Somaratne, R J, Whitbourn
openaire +2 more sources
Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (ABSORB™): 2-year results from the GABI-R-registry. [PDF]
Pahmeier K +17 more
europepmc +1 more source
Bioresorbable Vascular Scaffolds in Women
Gennaro, Giustino, George D, Dangas
openaire +2 more sources
Late structural discontinuity after bioresorbable vascular scaffold implantation in patients with in-stent restenosis. [PDF]
Cuesta J +3 more
europepmc +1 more source
Modelling Stretch Blow Moulding of Poly (l-lactic acid) for the Manufacture of Bioresorbable Vascular Scaffold. [PDF]
Wei H, Yan S, Menary G.
europepmc +1 more source
From the real device to the digital twin: A coupled experimental-numerical strategy to investigate a novel bioresorbable vascular scaffold. [PDF]
Antonini L +6 more
europepmc +1 more source

